Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Randomised, Double Blind, Clinical Trial Investigating the Effectiveness of Repurposed Simvastatin Compared to Placebo, in Secondary Progressive Multiple Sclerosis, in Slowing the Progression of Disability

NCT03387670 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03387670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03387670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Randomised, Double Blind, Clinical Trial Investigating the Effectiveness of Repurposed Simvastatin Compared to Placebo, in Secondary Progressive Multiple Sclerosis, in Slowing the Progression of Disability
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Completed
Start date
March 28, 2018
Completion date
August 25, 2024
Enrollment
964 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

secondary progressive multiple sclerosis (spms)